Literature DB >> 19172435

Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.

Su Jin Jeong1, Heekyung Choi, Han Sung Lee, Sang Hoon Han, Bum Sik Chin, Ji-Hyeon Baek, Chang Oh Kim, Jun Yong Choi, Young Goo Song, June Myung Kim.   

Abstract

Infection is a major cause of mortality in patients with systemic lupus erythematosus (SLE). This study describes infectious complications in SLE patients and analyzes the risk factors for infection at the time of SLE diagnosis and during the course of SLE in a case-control study. Of 110 patients enrolled, 42 (38%) had at least 1 episode of infectious disease. The incidence of infectious disease was 4.4/100 patient-years (py) with a total follow-up duration of 954 y. In multivariate analysis, independent predictors of infection at the time of SLE diagnosis were an SLE disease activity index (SLEDAI) > 12 (p = 0.01), C3 levels < 90 mg/dl (p = 0.01) and positive anti-ds DNA antibodies (p < 0.01). Frequent flare-ups (p = 0.04) and follow-up duration > or =8 y (p = 0.023) were also significant risk factors for infectious diseases. It is mandatory to closely observe SLE patients with risk factors for developing infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172435     DOI: 10.1080/00365540902744741

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  17 in total

1.  Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.

Authors:  Abdul Hakkim; Barbara G Fürnrohr; Kerstin Amann; Britta Laube; Ulrike Abu Abed; Volker Brinkmann; Martin Herrmann; Reinhard E Voll; Arturo Zychlinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

2.  Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.

Authors:  Chengcheng Hou; Ou Jin; Xi Zhang
Journal:  Clin Rheumatol       Date:  2018-07-09       Impact factor: 2.980

3.  Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Authors:  Maria G Tektonidou; Zhong Wang; Abhijit Dasgupta; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

Review 4.  Diagnosis and management of infectious complications of childhood rheumatic diseases.

Authors:  Rhina D Castillo; Wendy De la Pena; Katherine A B Marzan
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

Review 5.  Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus.

Authors:  Brendan M Giles; Susan A Boackle
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Systemic Lupus Erythematosus is a Risk Factor for Complications in Total Joint Arthroplasty.

Authors:  J Joseph Gholson; Brandon G Wilkinson; Timothy S Brown; Yubo Gao; S Blake Dowdle; John J Callaghan
Journal:  Iowa Orthop J       Date:  2018

7.  Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

Authors:  Dalia F Mohamed; Reem A Habeeb; Sherin M Hosny; Shafika E Ebrahim
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2014-07-30

8.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

9.  Rapid and precise diagnosis of pneumonia coinfected by Pneumocystis jirovecii and Aspergillus fumigatus assisted by next-generation sequencing in a patient with systemic lupus erythematosus: a case report.

Authors:  Yili Chen; Lu Ai; Yingqun Zhou; Yating Zhao; Jianyu Huang; Wen Tang; Yujian Liang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-06-26       Impact factor: 3.944

10.  Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus.

Authors:  Thozama Dubula; Girish M Mody
Journal:  Clin Rheumatol       Date:  2014-12-23       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.